New gene therapies developed using CRISPR gene editing offer the promise of treating or even curing debilitating diseases.

Three patients are in “safe, deep remission” after receiving a CRISPR-Cas9-modified cell therapy for autoimmune disease ...

Cas9, a technology that has moved from lab to clinic at lightning speed. Scientists have already used gene editing to improve ...

Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass ...

Here are some of the most groundbreaking developments in science this week, ranging from a novel approach to rejuvenating ...

As of October 2024, there are more than thirty FDA-approved gene therapies, spanning a diverse array of diseases such as ...

CRISPR genome editing is revolutionizing medicine. Rapid market growth, fueled by startups and new therapies, brings ethical ...

The treatment, involving the use of donor cells, has shown positive results in patients six months after receiving treatment.

Discover how genetic mutations, like BRCA1 and BRCA2, impact cancer risk and personalized treatment strategies.

The Daily Targum is where you can find Rutgers University's campus news, Scarlet Knights sports coverage, features, opinions ...

For the biopharma industry to match the pace of genomic innovations and speed new therapies to market, it will need to ...